News
Latest News
In 2025, NewYorkBIO launched New York Bio Connect, a first-of-its-kind resource hub. Designed for…
The award celebrates innovation, economic impact, and leadership in New York City’s thriving life sciences…
New York’s leading life science advocacy association and economic development organizations develop resource…
Statement on Behalf of Jennifer Hawks Bland, CEO of NewYorkBIO
Statement on behalf of Jennifer Hawks Bland, CEO of NewYorkBIO on Most Favored Nation Executive Order
New York, NY (April 23, 2025) – Mid Atlantic Bio Angels Group (MABA) and NewYorkBIO announced today a…
Statement from Jennifer Hawks Bland on National Security Commission on Emerging Biotechnology Report
NewYorkBIO joins BIO in expressing our gratitude to NSCEB for their years-long work to examine and present…
StatNews 03/10/2026
It's the third time in recent weeks that the FDA has admonished Novo Nordisk for different ...
03/10/2026
AI scribe company Nabla aims to be much more by using tech from Yann LeCun's new startup AMI, which ...
03/10/2026
Ugur Sahin and Özlem Türeci, the couple who co-founded BioNTech, are leaving the Covid-19 vaccine ...
03/09/2026
Vertex said a drug it secured as part of a $4.9 billion acquisition successfully reduced by half a ...
03/09/2026
Wall Street's verdict on Prasad, generic semaglutide's new pricing, and other biotech news
03/09/2026
Xenon Pharmaceuticals said its treatment for a common type of seizure disorder significantly ...
03/09/2026
The FDA is cutting back on public advisory committee meetings, even as the public and other ...
03/06/2026
Recent decisions at the FDA threaten to turn its disagreements with the drugmaker UniQure into ...
03/06/2026
Moderna's long-term strategy, an FDA fast-track for Janssen, and other biotech news from The Readout